James R. Tobin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Lexington, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for James R. Tobin

Form 4 holding Director

Lyra Therapeutics, Inc.

Security class
Stock Option
Shares / value
30,000
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

GLOBUS MEDICAL INC

Security class
Stock Option (Right to Buy Class A Common Stock)
Shares / value
15,000
Estimated value
Report date
21 Jan 2026
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

TransMedics Group, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
1,154
Estimated value
Report date
23 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by James R. Tobin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .